MTOR and acute myeloid leukemia: Indeed, simultaneous inhibition of PI3K, mTOR, and MAPK/ERK synergistically induced cell death in AML cells, which was further enhanced by the addition of venetoclax, while sparing the normal hematopoietic progenitor cells [287,297].